Subscribe to Newsletter

Business & Regulation

Business & Regulation Profession

Growing, Adapting, Leading

| Angus Stewart, Stephanie Vine

We interview Mary Lavin, President of Sartorius North America, about her career.

Business & Regulation Business Practice

Come Get Your Leaves

| Angus Stewart

Andes-based cannabis cultivator Clever Leaves pledges to send US$25 million of leaves to US researchers.

Business & Regulation Standards & Regulation

High Fines for High Prices

| Stephanie Vine

Advanz Pharma is fined for substantially hiking the price of a generic drug.

Business & Regulation Standards & Regulation

The Winding Road to the Frontline for Advanced Therapies

| Angi Robinson

How can we ease the process of taking ATMPs to clinical trials? Two experts lay out the key considerations.

Business & Regulation Standards & Regulation

A Year Like No Other

| Maryam Mahdi

The EMA releases its annual report highlighting its achievements throughout 2020.

Business & Regulation Standards & Regulation

Watching the Future

| James Strachan

We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.

Business & Regulation Business Practice

The Digital Advantage

| Maryam Mahdi

How can pharma make the most of digital technologies?

Business & Regulation Drug Discovery

A Meeting of Mind Menders

| Angus Stewart

GSK forms strategic partnership with Alector to produce monoclonal antibodies for neurodegenerative diseases.

Business & Regulation Profession

People, Process, Product: Lessons Learned with Antoinette Gawin

| James Strachan

Find out how a random act of kindness set Antoinette Gawin on the path to becoming a VP in her twenties.

Business & Regulation Business Practice

Think of the Patients

| Stephanie Vine

GlaxoSmithKline’s Senior Vice President of US Oncology speaks about the pandemic and its impact on patients.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register